Search details
1.
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Hepatology
; 2024 Mar 13.
Article
in English
| MEDLINE | ID: mdl-38478755
2.
Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations.
Z Gastroenterol
; 61(1): 71-75, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36379463
3.
Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review.
Dig Dis
; 40(5): 565-580, 2022.
Article
in English
| MEDLINE | ID: mdl-34644705
4.
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol.
Future Oncol
; 18(12): 1423-1435, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35081747
5.
Liver Transplantation for Acute Intermittent Porphyria.
Liver Transpl
; 27(4): 491-501, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33259654
6.
Prevalence, Resistance Rates, and Risk Factors of Pathogens in Routine Bile Cultures Obtained during Endoscopic Retrograde Cholangiography.
Dig Dis
; 39(1): 42-51, 2021.
Article
in English
| MEDLINE | ID: mdl-32521535
7.
IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease.
Int J Mol Sci
; 21(22)2020 Nov 14.
Article
in English
| MEDLINE | ID: mdl-33202693
8.
Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model.
Lab Invest
; 99(12): 1906-1917, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31467426
9.
Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors.
BMC Cancer
; 19(1): 575, 2019 Jun 13.
Article
in English
| MEDLINE | ID: mdl-31196127
10.
The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.
Digestion
; 100(1): 15-26, 2019.
Article
in English
| MEDLINE | ID: mdl-30282074
11.
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
J Hepatol
; 67(3): 549-558, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28529147
13.
Extending the Use of Atezolizumab and Bevacizumab to a Liver Transplant Recipient: Need for a Posttransplant Registry.
Liver Transpl
; 27(6): 928-929, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33570764
14.
Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.
Liver Transpl
; 22(1): 42-52, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26438008
15.
1,25-(OH)2-vitamin D3 prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-) model.
Biochem Biophys Res Commun
; 459(2): 227-233, 2015 Apr 03.
Article
in English
| MEDLINE | ID: mdl-25712522
16.
Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment.
Am J Gastroenterol
; 115(12): 2114-2116, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32852335
17.
Monitoring Dual-Cancer Treatment in a Patient With Prostate and Hepatocellular Carcinoma Using Prostate-Specific Membrane Antigen-Directed PET/CT.
Clin Nucl Med
; 49(5): 442-443, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38389205
18.
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.
Liver Cancer
; 13(1): 6-28, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38344449
19.
The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology.
Aging Dis
; 15(1): 338-356, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-37307826
20.
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events.
JHEP Rep
; 6(6): 101065, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38798717